PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30378732-5	2020	Our findings show that selective alpha3beta4* nAChR antagonist, AuIB, and alpha3beta4* nAChR partial agonist, AT-1001, dose-dependently attenuated somatic withdrawal signs in THC-dependent mice that were challenged with the cannabinoid-1 receptor antagonist rimonabant.	Rimonabant	258-268	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	87-92